Medium materiality6/10
Medpace price target raised to $665 from $586 at Mizuho
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised to 665; price 605.82; upside potential remains though price recently eased.
- Target 665; price 605.82
Key facts
- 01
Target: $665
- 02
Posted price: $605.82
- 03
Analyst firm: Mizuho Securities
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.